Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19

Since December 2019, coronavirus disease 2019 (COVID-19) caused by a novel coronavirus has spread all over the world affecting tens of millions of people. Another pandemic affecting the modern world, type 2 diabetes mellitus is among the major risk factors for mortality from COVID-19. Current eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Futatsugi, Hiroyuki, Iwabu, Masato, Okada-Iwabu, Miki, Okamoto, Koh, Amano, Yosuke, Morizaki, Yutaka, Kadowaki, Takashi, Yamauchi, Toshimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655538/
https://www.ncbi.nlm.nih.gov/pubmed/33195481
http://dx.doi.org/10.3389/fcvm.2020.593061
Descripción
Sumario:Since December 2019, coronavirus disease 2019 (COVID-19) caused by a novel coronavirus has spread all over the world affecting tens of millions of people. Another pandemic affecting the modern world, type 2 diabetes mellitus is among the major risk factors for mortality from COVID-19. Current evidence, while limited, suggests that proper blood glucose control may help prevent exacerbation of COVID-19 even in patients with type 2 diabetes mellitus. Under current circumstances where the magic bullet for the disease remains unavailable, it appears that the role of blood glucose control cannot be stressed too much. In this review the profile of each anti-diabetic agent is discussed in relation to COVID-19.

Ejemplares similares